1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways
(
- Contribution to journal › Article
- 2023
-
Mark
Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
(
- Contribution to journal › Article
- 2022
-
Mark
SRIQ clustering : A fusion of Random Forest, QT clustering, and KNN concepts
(
- Contribution to journal › Article
- 2021
-
Mark
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
(
- Contribution to journal › Article
-
Mark
Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives
(
- Contribution to journal › Article
-
Mark
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
- 2020
-
Mark
ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
(
- Contribution to journal › Article
- 2016
-
Mark
Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma
(
- Contribution to journal › Article
- 1993
-
Mark
Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage
(
- Contribution to journal › Article